Yuzhen Liang

机构：Guangxi Medical University · ORCID：0000-0002-4982-7434

发表论文 42 篇 · 总被引 639 次 · h-index 17

代表论文

• GLP-1RA Liraglutide and Semaglutide Improves Obesity-Induced Muscle Atrophy via SIRT1 Pathway (2023 · Diabetes Metabolic Syndrome and Obesity · 被引 94)
• <p>Liraglutide Improves Non-Alcoholic Fatty Liver Disease In Diabetic Mice By Modulating Inflammatory Signaling Pathways</p> (2019 · Drug Design Development and Therapy · 被引 40)
• Applications of Clinical Decision Support Systems in Diabetes Care: Scoping Review (2023 · Journal of Medical Internet Research · 被引 38)
• <p>Liraglutide ameliorates nonalcoholic fatty liver disease in diabetic mice via the IRS2/PI3K/Akt signaling pathway</p> (2019 · Diabetes Metabolic Syndrome and Obesity · 被引 34)
• <p>Effects of liraglutide on lipolysis and the AC3/PKA/HSL pathway</p> (2019 · Diabetes Metabolic Syndrome and Obesity · 被引 30)
• <p>Guava Leaf Extract Attenuates Insulin Resistance via the PI3K/Akt Signaling Pathway in a Type 2 Diabetic Mouse Model</p> (2020 · Diabetes Metabolic Syndrome and Obesity · 被引 28)